Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 2168767, 9 pages
https://doi.org/10.1155/2017/2168767
Research Article

miR-217 Is a Useful Diagnostic Biomarker and Regulates Human Podocyte Cells Apoptosis via Targeting TNFSF11 in Membranous Nephropathy

1Department of General Medicine, Sichuan Cancer Hospital, Chengdu 610041, China
2Department of Medical Oncology, Sichuan Cancer Hospital, Chengdu 610041, China
3Department of Nephrology, Ya’an People’s Hospital, Ya’an 625000, China

Correspondence should be addressed to Ling Peng; moc.361@81787180981

Received 29 June 2017; Revised 24 September 2017; Accepted 1 October 2017; Published 30 October 2017

Academic Editor: Kui Li

Copyright © 2017 Jing Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Aaltonen and E. Honkanen, “Outcome of idiopathic membranous nephropathy using targeted stepwise immunosuppressive treatment strategy,” Nephrology Dialysis Transplantation , vol. 26, no. 9, pp. 2871–2877, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Ponticelli and P. Passerini, “Can prognostic factors assist therapeutic decisions in idiopathic membranous nephropathy?” Journal of Nephrology, vol. 23, no. 2, pp. 156–163, 2010. View at Google Scholar · View at Scopus
  3. E. J. Filippone and J. L. Farber, “Membranous nephropathy in the kidney allograft,” Clinical Transplantation, vol. 30, no. 11, pp. 1394–1402, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. D. C. Cattran, E. D. Kim, H. Reich, M. Hladunewich, and S. J. Kim, “Membranous nephropathy: quantifying remission duration on outcome,” Journal of the American Society of Nephrology, vol. 28, no. 3, pp. 995–1003, 2017. View at Publisher · View at Google Scholar
  5. M. Nangaku, S. J. Shankland, and W. G. Couser, “Cellular response to injury in membranous nephropathy,” Journal of the American Society of Nephrology, vol. 16, no. 5, pp. 1195–1204, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. S. J. Lee, E. Borsting, A.-E. Declèves, P. Singh, and R. Cunard, “Podocytes express IL-6 and lipocalin 2/neutrophil gelatinase-associated lipocalin in lipopolysaccharide-induced acute glomerular injury,” Nephron Experimental Nephrology, vol. 121, no. 3-4, pp. e86–e96, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. N. M. Tomas, E. Hoxha, A. T. Reinicke et al., “Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy,” The Journal of Clinical Investigation, vol. 126, no. 7, pp. 2519–2532, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. W. G. Couser, “Membranous nephropathy: A long road but well traveled,” Journal of the American Society of Nephrology, vol. 16, no. 5, pp. 1184–1187, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Praga and J. Rojas-Rivera, “Glomerular disease: Predicting outcomes in idiopathic membranous nephropathy,” Nature Reviews Nephrology, vol. 8, no. 9, pp. 496–498, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. V. N. Kim and J. W. Nam, “Genomics of microRNA,” Trends in Genetics, vol. 22, no. 3, pp. 165–173, 2006. View at Publisher · View at Google Scholar
  12. J. Krol, I. Loedige, and W. Filipowicz, “The widespread regulation of microRNA biogenesis, function and decay,” Nature Reviews Genetics, vol. 11, no. 9, pp. 597–610, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Navarro-Quiroz, L. Pacheco-Lugo, H. Lorenzi et al., “High-throughput sequencing reveals circulating miRNAs as potential biomarkers of kidney damage in patients with systemic lupus erythematosus,” PLoS ONE, vol. 11, no. 11, Article ID e0166202, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Fan, C. Chen, Y. Chen, Y. Chang, and P. Chu, “MicroRNAs in acute kidney injury,” Human Genomics, vol. 10, no. 1, 2016. View at Publisher · View at Google Scholar
  15. S. Hajarnis, R. Lakhia, and V. Patel, “MicroRNAs and Polycystic Kidney Disease,” in Polycystic Kidney Disease, X. Li, Ed., 2015. View at Google Scholar
  16. J. L. Wang, X. Wang, D. Yang, and W. Shi, “The Expression of MicroRNA-155 in plasma and tissue is matched in human laryngeal squamous cell carcinoma,” Yonsei Medical Journal, vol. 57, no. 2, pp. 298–305, 2016. View at Publisher · View at Google Scholar
  17. Y. Jiao, M. Zhu, X. Mao, M. Long, X. Du, and Y. Wu, “MicroRNA-130a expression is decreased in Xinjiang Uygur patients with type 2 diabetes mellitus,” American Journal of Translational Research, pp. 1984–91, 2015. View at Google Scholar
  18. X. Chen, Y. Ba, L. Ma et al., “Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases,” Cell Research, vol. 18, no. 10, pp. 997–1006, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Guclu, C. Kocak, FE. Kocak, R. Akcilar, Y. Dodurga, A. Akcilar et al., “Micro RNA-320 as a novel potential biomarker in renal ischemia reperfusion,” Renal Failure, vol. 38, pp. 1468–1475, 2016. View at Google Scholar
  20. F. Trevisani, M. Ghidini, A. Larcher et al., “MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma,” British Journal of Cancer, vol. 115, no. 11, pp. 1343–1350, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. W. Chen, X. Lin, J. Huang et al., “Integrated profiling of microRNA expression in membranous nephropathy using high-throughput sequencing technology,” International Journal of Molecular Medicine, vol. 33, no. 1, pp. 25–34, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Qin, L. H. Beck Jr., C. Zeng et al., “Anti-phospholipase A2 receptor antibody in membranous nephropathy,” Journal of the American Society of Nephrology, vol. 22, no. 6, pp. 1137–1143, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. Q. Zhang, C. Zeng, Z. Cheng, K. Xie, J. Zhang, and Z. Liu, “Primary focal segmental glomerulosclerosis in nephrotic patients: Common complications and risk factors,” Journal of Nephrology, vol. 25, no. 5, pp. 679–688, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. K. G. M. M. Alberti and P. Z. Zimmet, “Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation,” Diabetic Medicine, vol. 15, no. 7, pp. 539–553, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. P. S. Mitchell, R. K. Parkin, E. M. Kroh et al., “Circulating microRNAs as stable blood-based markers for cancer detection,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 105, no. 30, pp. 10513–10518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. E. M. Kroh, R. K. Parkin, P. S. Mitchell, and M. Tewari, “Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR),” Methods, vol. 50, no. 4, pp. 298–301, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Idasiak-Piechocka, A. Oko, K. Łochyńska-Bielecka, and B. Skrobańska, “Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy,” Kidney and Blood Pressure Research, vol. 32, no. 4, pp. 263–267, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. A. S. Flynt and E. C. Lai, “Biological principles of microRNA-mediated regulation: shared themes amid diversity,” Nature Reviews Genetics, vol. 9, no. 11, pp. 831–842, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. Cortez and G. A. Calin, “MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases,” Expert Opinion on Biological Therapy, vol. 9, no. 6, pp. 703–711, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. I.-T. Lee, C.-C. Lin, S.-E. Cheng, L.-D. Hsiao, Y.-C. Hsiao, and C.-M. Yang, “TNF-α Induces Cytosolic Phospholipase A2 Expression in Human Lung Epithelial Cells via JNK1/2- and p38 MAPK-Dependent AP-1 Activation,” PLoS ONE, vol. 8, no. 9, Article ID e72783, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. P.-L. Chi, C.-J. Liu, I.-T. Lee, Y.-W. Chen, L.-D. Hsiao, and C.-M. Yang, “HO-1 induction by CO-RM2 attenuates TNF- α -induced cytosolic phospholipase A2 expression via inhibition of PKC α -dependent NADPH oxidase/ROS and NF- B,” Mediators of Inflammation, vol. 2014, Article ID 279171, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. D. M. Anderson, E. Maraskovsky, W. L. Billingsley et al., “A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function,” Nature, vol. 390, no. 6656, pp. 175–179, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Yi, H.-L. Lee, J.-H. Cha et al., “Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling,” Journal of Cellular Physiology, vol. 217, no. 2, pp. 409–422, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Sugatani, U. M. Alvarez, and K. A. Hruska, “Activin A stimulates IκB-α/NFκB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors,” Journal of Cellular Biochemistry, vol. 90, no. 1, pp. 59–67, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Saito, M. Okamura, S. Nakajima et al., “Suppression of nephrin expression by TNF-α via interfering with the cAMP-retinoic acid receptor pathway,” American Journal of Physiology-Renal Physiology, vol. 298, no. 6, pp. F1436–F1444, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. M. D. Sanchez-Nio, A. Benito-Martin, S. Gonalves et al., “TNF superfamily: a growing saga of kidney injury modulators,” Mediators of Inflammation, vol. 2010, Article ID 182958, 11 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Ronco and H. Debiec, “New insights into the pathogenesis of membranous glomerulonephritis,” Current Opinion in Nephrology and Hypertension, vol. 15, no. 3, pp. 258–263, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Esquela-Kerscher and F. J. Slack, “Oncomirs—microRNAs with a role in cancer,” Nature Reviews Cancer, vol. 6, no. 4, pp. 259–269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. R. L. Skalsky and B. R. Cullen, “Viruses, microRNAs, and host interactions,” Annual Review of Microbiology, vol. 64, pp. 123–141, 2010. View at Publisher · View at Google Scholar · View at Scopus